|
|
The goal of the evaluation and treatment of jaundice
(hyperbilirubinemia) in the newborn infant is to prevent the
development of severe hyperbilirubinemia which could lead to
kernicterus. The American Academy of Pediatrics has developed
recommendations to help physicians and other health care professionals
caring for newborns manage and treat jaundice. These recommendations
include :
- the promotion and support of successful breastfeeding,
- the establishment of protocols for evaluation and treatment of
jaundice in hospitalized newborns,
- the measurement of serum bilirubin levels in infants jaundiced in
the first 24 hours of life,
- the interpretion of bilirubin levels according to the infant's age
in hours.
See
Management of hyperbilirubinemia in the newborn infant 35 or more weeks
of gestation. Page 301.
- the recognition that breastfed infants < 38 weeks gestation are at
higher risk of the development of jaundice and require closer
monitoring,
- the assessment of all infants prior to newborn discharge for risk
of severe hyperbilirubinemia,
- that all parents receive information about jaundice,
- the provision of outpatient follow-up based on age at discharge
and other risk factors, and
- the use of phototherapy or exchange transfusion when indicated
(
AAP Jaundice, 2004
).
|